ArticleAlzheimer's & dementia (New York, N. Y.)

Infusion-related reactions in donanemab-treated participants with early symptomatic Alzheimer's disease.

Paul Ardayfio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.